| Literature DB >> 26797311 |
Lisa A Shender1, Michael D Lewis2, Daniel Rejmanek1, Jonna A K Mazet1.
Abstract
BACKGROUND: Trypanosoma cruzi, causative agent of Chagas disease in humans and dogs, is a vector-borne zoonotic protozoan parasite that can cause fatal cardiac disease. While recognized as the most economically important parasitic infection in Latin America, the incidence of Chagas disease in the United States of America (US) may be underreported and even increasing. The extensive genetic diversity of T. cruzi in Latin America is well-documented and likely influences disease progression, severity and treatment efficacy; however, little is known regarding T. cruzi strains endemic to the US. It is therefore important to expand our knowledge on US T. cruzi strains, to improve upon the recognition of and response to locally acquired infections. METHODOLOGY/PRINCIPLEEntities:
Mesh:
Year: 2016 PMID: 26797311 PMCID: PMC4721664 DOI: 10.1371/journal.pntd.0004291
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
Trypanosoma cruzi PCR assays used for screening, discrete typing unit (DTU), and phylogenetic analyses.
| PCR assay | Forward/Reverse Primers & (Reaction conditions) | bp | Cycling conditions (‘ = minutes;” = seconds) | Cloning |
|---|---|---|---|---|
| TcZ1: 5'-CGA GCT CTT GCC CAC ACG GGT GCT-3' / TcZ2: 5'-CCT CCA AGC AGC GGA TAG TTC AGG-3' (20μl: 1.9mM MgCl2, 0.2mM each dNTPs, 0.5μM each primer, 0.25U Taq & 4μl buffer) | 188 | 94° x 5’ (94° x 20”, 57° x 10”, 72° x 30”)35; 72° x 7’ | 1 | |
| 121: 5'-AAA TAA TGT ACG GGK GAG ATG CAT GA-3' / 122: 5'-GGT TCG ATT GGG GTT GGT GTA ATA TA-3' (25μl: 1.5mM MgCl2, 0.2mM each dNTPs, 0.4μM each primer, 0.625U Taq & 5μl buffer) | 330 | 95° x 10’ (94° x 30”, 58° x 30”, 72° x 1’)35; 72° x 10’ | 1 | |
| D71: 5'-AAG GTG CGT CGA CAG TGT GG-3' / D72: 5'-TTT TCA GAA TGG CCG AAC AGT-3' (25μl: 1.5mM MgCl2, 0.1mM each dNTPs, 0.4μM each primer, 1U Taq & 5μl buffer) | varies | 94° x 3’ (94° x 1’, 60° x 1’, 72° x 1’)35; 72° x 10’ | 1 | |
| For: 5'-GTG GTA TGG G TGA CAT GTA C-3' / Rev: 5'-CGA GCA GCA G AGC GAA ACA T-3' (50μl: 2mM MgCl2, 0.1mM each dNTPs, 0.4μM each primer, 2U Taq & 13.3μl buffer) | 432–462 prior to RFLP | 94° x 3’ (94° x 30”, 52° x 30”, 72° x 1’)35; 72° x 10’ | 1 | |
| TC: 5’-CCC CCC TCC CAG GCC ACA CTG-3’ / TC1: 5’- GTG TCC GCC ACC TCC TTC GGG CC-3’ / TC2: 5’-CCT GCA GGC ACA CGT GTG TGT G-3’ (25μl: 1.5 MgCl2, 0.2mM each dNTPs, 1μM each primer, 1U Taq & 5μl buffer) | varies | 94° x 3’ (94° x 30”, 60° x 30”, 72° x 30”)27; 72° x 10’ | 1 | |
| For: 5'-GGC ATG TGA AGC TTT GAG GCC TTT TTC AG-3' / Rev: 5'-TGT AAG GGC CCA GTG AGA GCG TTC GTT GAA TAG C-3' (50μl: 2mM MgCl2, 0.1mM each dNTPs, 0.4μM each primer, 2U Taq & 13.3μl buffer) | 1264 prior to RFLP | 94° x 3’ (94° x 30”, 52° x 30”, 72° x 1’)35; 72° x 10’ | 1 | |
| ND3.1A: 5’-GCT ACT ART TCA CTT TCA CAT TC-3’ / COII.2A: 5’-GCA TAA ATC CAT GTA AGA CMC CAC A-3’ (25μl: 1.5 MgCl2, 0.2mM each dNTPs, 1μM each primer, 1U Taq & 5μl buffer) | 1272 | 94° x 5’ (94° x 30”, 50° x 30”, 72° x 30”)30; 72° x 7’ | 2 | |
| TR Y2S: 5’-ACT GGA GGC TGC TTG GAA CGC-3’ / TR Y2A: 5’-GGA TGC ACA CCR ATR GTG TTG T-3’ (25μl: 1.5 MgCl2, 0.2mM each dNTPs, 0.5μM each primer, 1U Taq & 5μl buffer) | 1335 | 94° x 5’ (94° x 1’, 55° x 1’, 72° x 1’)30; 72° x 5’ | 1 | |
| RB19F: 5’-GCC TAC ACC GAG GAG TAC CA-3’ / RB19R: 5’-TTC TCC AAT CCC CAG ACT TG-3’ (25μl: 1.5 MgCl2, 0.2mM each dNTPs, 0.5μM each primer, 1U Taq & 5μl buffer) | 408 | 94° x 5’ (94° x 1’, 55° x 1’, 72° x 1’)30; 72° x 5’ | 3 |
1Bracketed numbers correspond to the original references for each assay. S = Screening; P = Phylogenetic
2The target base pair amplicon sizes; for some assays the size varies by the discrete typing unit as depicted in Fig 1
3Cloning methods were M13 PCR amplification followed by ExoSapIT (1), Qiagen MiniPrep method followed by EcoRI digestion (2), or direct sequencing without cloning (3).
4See Fig 1 for details on the restriction fragment length polymorphism (RFLP) banding pattern for HSP60 and GPI.
5Multiplex PCR assay with three primers.
Fig 1PCR assay flowsheet1 to identify Trypanosoma cruzi discrete typing units (DTUs).
Directional arrows indicate assay order and stop signs denote when sufficient data was gathered to theoretically identify the DTU. The final assay (GPI) is included as a confirmatory step, but is not required for DTU identification. 1Modified from Lewis et al. [37] 2The large subunit rDNA assay is also referred to as the 24sα rRNA gene assay. 3An additional band of approximately 125bp may or may not be visible in combination with the 110bp band. 4Heat Shock Protein-60 (HSP60) results in an amplicon of 432-462bp, which upon RFLP with EcoV restriction enzyme yields the following patterns: 1 band (432–462), 2 bands (118–148 + 314), or 3 bands (118–148 + 314 + 432–462). 5This PCR used a pool of three primers to amplify a portion of the non-transcribed intergenic region of the tandemly repeated mini-exon gene. 6Glucose Phosphate Isomerase (GPI) results in an amplicon of approximately 1264bp, which upon RFLP with HhaI restriction enzyme yields the following patterns: 2 bands (447 + 817), 3 bands (253 + 447 + 490), or 4 bands (253 + 447 + 490 + 817). TcIV will display 2 or 3 bands for North American and South American strains, respectively.
Trypanosoma cruzi results for Triatoma protracta specimens.
Represented are screening results for all samples tested and discrete typing units (I or IV) for a subset of specimens from each geographic region, based on phylogenetic assays.
| Region = % (n/N) | Sample ID | |||
|---|---|---|---|---|
| Vallecito = 55 (16/29) | Vall3 | I | I | I |
| Vall7 | I | I | I | |
| Vall8 | I | I | I | |
| Vall13 | I | I | I | |
| Vall14 | I | I | I | |
| LA Region = 20 (3/15) | SoCal1 | I | I | I |
| SoCal2 | I | I | I | |
| SoCal3 | I | I | I | |
| Escondido = 34 (18/53) | Esc2 | I | I | I |
| Esc19 | IV | IV | IV | |
| Esc26 | IV | IV | I | |
| Esc46 | I | I | I |
1Percent bugs positive for each geographic region as determined by highly sensitive nuclear and kinetoplast screening assays (# positive/# tested). LA = Los Angeles.
2SoCal1 and SoCal2 were from Los Angeles and Santa Clarita, respectively. The exact location of SoCal3 was unknown. This bug was submitted from a health agency via a wildlife rehabilitation center in Ventura County. An opossum was transferred to the center from an animal shelter in Los Angeles County, and upon arrival, the bug was found in the bedding material within the opossum crate.
3Partial gene sequences were submitted to GenBank for RNA binding-protein-19 (RB19), trypanothione reductase (TR), and cytochrome oxidase/NADH dehydrogenase subunit 1 (COII-ND1) under the respective accession numbers: KR108801-KR108812, KR108813-KR108827 and KR135412-KR135425.
4Esc26, which displayed incongruency between nuclear (TcIV) and maxicircle (TcI) genes, was categorized as TcI via the DTU assays described in Fig 1.
Fig 2Phylogeny for 26 Trypanosoma cruzi 350 bp RNA-Binding Protein-19 (RB19) sequences.
Neighbor-Joining tree constructed in MEGA6 with evolutionary distances computed via Maximum Composite Likelihood. The numbers above the nodes represent bootstrap confidence levels for 2,000 replicates. Only values ≥ 50% are shown. The only TcI isolate not obtained in this study is represented by a square. Sequences obtained in this study are indicated by a triangle (Esc = Escondido, SoCal = Southern California, Vall = Vallecito). All other isolates represent published GenBank sequences as listed in S1 Table with their country origin indicated in parentheses. The scale bar indicates the number of nucleotide substitutions per site. Tree is outgroup rooted with T. cruzi marinkellei (TcMark CONTIG 1404).
Fig 3Phylogeny for 35 Trypanosoma cruzi 1288 bp trypanothione reductase sequences.
Depicted is the Neighbor-Joining (NJ) tree constructed in MEGA6 with evolutionary distances computed via the Maximum Composite Likelihood method and the scale bar indicating the number of nucleotide substitutions per site. The numbers above or below the nodes represent the bootstrap confidence levels for 2,000 NJ replicates (1st value) and 500 Maximum Likelihood replicates (2nd value presented at nodes with congruent topologies) run under the Kimura 2-parameter model for those values ≥ 50%. Sequences obtained in this study are indicated by the triangles (Esc = Escondido, SoCal = Southern California, Vall = Vallecito). All other isolates represent published GenBank sequences as listed in S1 Table with their country of origin indicated in parentheses. Tree is outgroup rooted with T. cruzi marinkellei (GenBank #AF359007).
Fig 4Phylogeny for 62 Trypanosoma cruzi concatenated 786 bp cytochrome oxidase II-NADH 1 (COII-ND1) sequences.
The TcI clade is condensed in this figure and contains the majority of the sequences obtained in this study (see Fig 5 for expanded version). Depicted is the Neighbor-Joining (NJ) tree constructed in MEGA6 with evolutionary distances computed via the Maximum Composite Likelihood method and the scale bar indicating the number of nucleotide substitutions per site. The numbers above or below the nodes represent the bootstrap confidence levels for 2,000 NJ replicates (1st value) and 500 Maximum Likelihood replicates run under the Tamura 3-parameter model (due to slightly incongruent topology, ML bootstrap values are only shown at three nodes) for those values ≥ 50%. Only one sequence obtained in this study (Esc19 = Escondido 19) was grouped as TcIV based on mitochondrial gene sequences. All other isolates represent published GenBank sequences as listed in S1 Table with their country of origin indicated in parentheses. Tree is outgroup rooted with T. cruzi marinkellei (GenBank #AF359054).
Fig 5TcI subtree represented as TcI on Fig 4 showing four distinct subclades.
This subtree includes 46 COII-ND1 concatenated sequences (786 bp). The scale bar indicates the number of nucleotide substitutions per site for the NJ tree. The numbers above or below the nodes represent the bootstrap confidence levels for 2,000 NJ replicates (1st value) and 500 Maximum Likelihood replicates run under the Tamura 3-parameter model. Only bootstrap values ≥ 50% are shown. Sequences obtained in this study are indicated by the triangles (Esc = Escondido, SoCal = Southern California, Vall = Vallecito). Esc26 was grouped with TcI in this analysis but was grouped with TcIV in all other analyses. All other isolates represent published GenBank sequences as listed in S1 Table with their country of origin indicated in parentheses.
Mean uncorrected pairwise-distances for Esc26.
Each p-distance represents the average proportion of nonidentical nucleotide positions between Esc26 and the TcI and TcIV T. cruzi sequences used to generate the RNA-binding protein-19 (RB19), trypanothione reductase (TR) and cytochrome oxidase II-NADH 1 (COII-ND1) phylogenetic trees. The number of nucleotide positions (bp) for each gene is indicated, as is the number of comparison sequences (n) evaluated within each category.
| TcI | TcIV | |||
|---|---|---|---|---|
| Genetic Marker (bp) | p-distance (SD) | n | p-distance (SD) | n |
| 0.0198 (0.00174) | 14 | 0.00143 (0.00286) | 4 | |
| 0.0163 (0.00106) | 22 | 0.00684 (0.00321) | 4 | |
| 0.00592 (0.00489) | 46 | 0.0769 (0.00192) | 6 | |
Comparative diversity indices for Trypanosoma cruzi TcI sequences obtained from Triatoma protracta specimens collected in California, USA.
The data is represented for the overall combined (Total) populations, as well as at the regional population level (North = Vallecito; South = Escondido and Los Angeles area).
| Gene | Pop | bp | No. H | Hd | Pi | G+C | S | nSyn mut | Syn mut | dN/dS |
|---|---|---|---|---|---|---|---|---|---|---|
| Total | 368 | 1 (20) | 0.000 | 0.00000 | 0.568 | 0 | 0 | 0 | n/c | |
| North | 368 | 1 (10) | 0.000 | 0.00000 | 0.568 | 0 | 0 | 0 | n/c | |
| South | 368 | 1 (10) | 0.000 | 0.00000 | 0.568 | 0 | 0 | 0 | n/c | |
| Total | 1288 | 10 (24) | 0.913 | 0.00231 | 0.525 | 17 | 13 | 4 | 1.0150 | |
| North | 1288 | 5 (10) | 0.889 | 0.00304 | 0.526 | 11 | 9 | 2 | 1.4032 | |
| South | 1288 | 8 (14) | 0.884 | 0.00770 | 0.525 | 8 | 6 | 2 | 0.9379 | |
| Total | 1225 | 11 (24) | 0.935 | 0.00287 | 0.262 | 18 | nd | nd | nd | |
| North | 1225 | 5 (10) | 0.867 | 0.00214 | 0.262 | 10 | nd | nd | nd | |
| South | 1225 | 6 (14) | 0.868 | 0.00227 | 0.261 | 8 | nd | nd | nd |
1Table abbreviations: Pop = population region, bp = Base pair alignment length, No. H = number of unique haplotypes (total number of haplotypes analyzed), Hd = haplotype diversity, Pi = nucleotide diversity, G+C = Total G+C content, S = number of segregating sites (singleton + parsimony informative sites), nSyn mut = Number of non-synonymous mutations, Syn mut = Number of synonymous mutations, n/c = not calculable, n/d = not done due to putative RNA editing of this maxicircle gene.